News Sentiment

ADAG sentiment intelligence

Adagene Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 52 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 3.94 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

76/100 classification confidence.

Company focus 42

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-11.9% over one week, +10.4% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Guggenheim reiterates Adagene stock Buy rating on competitor shift

Market Reaction

Price moving ahead of tone

59/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 76/100 classification
One-week reaction -11.9% Price reacting lower
Trend fit Trend active 10.4% over four weeks
Fair value 68.2% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 29
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 42
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
TradingView 8
TradingKey 5
dars.gov.et 4
GlobeNewswire 4
Quartr 3
Stock Titan 3
DonanımHaber 3

Event Lens

What the news is about

Classified themes
Market update 21
Earnings 20
Analyst action 5
Balance sheet 1
Capital return 1
Deals and strategy 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-50 of 50
Benzinga Direct company coverage

12 Health Care Stocks Moving In Thursday's After-Market Session

This article lists 12 healthcare stocks that experienced significant movement in Thursday's after-market session. It highlights both gainers, such as Akari Therapeutics and BioNTech, and losers, including NervGen Pharma and Adagene, along with their respective percentage changes

Tone
Negative 33/100
Event
Market update
Published
21 May 2026 21:09
Source
Benzinga
Stock Titan Direct company coverage

WuXi entities report 3.49M-share stake in Adagene (NASDAQ: ADAG)

WuXi PharmaTech Healthcare Fund I L.P. and its parent, WuXi AppTec Co., Ltd., have reported beneficial ownership of 3,485,038 ordinary shares in Adagene Inc. (NASDAQ: ADAG), equivalent to 2,788,030 American Depositary Shares (ADS), amounting to a 5.9% stake. This information was

Tone
Neutral 50/100
Event
Deals and strategy
Published
15 May 2026 20:10
Source
Stock Titan
GlobeNewswire Direct company coverage

Adagene to Participate in Two Upcoming Investor Conferences

Adagene Inc. (Nasdaq: ADAG) announced that its senior management will participate in two upcoming investor conferences: the Stifel Annual Virtual Oncology Event on May 19-20, 2026, and the Jefferies LLC Global Healthcare Conference from June 2-4, 2026. The company will hold one-o

Tone
Positive 70/100
Event
Market update
Published
12 May 2026 12:09
Source
GlobeNewswire
Zacks Investment Research Direct company coverage

Should I buy Adagene (ADAG)

Tone
Positive 66/100
Event
Market update
Published
13 Feb 2021 07:14
Source
Zacks Investment Research